Joint Formulary & PAD

Losartan with hydrochlorothiazide - Hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Losartan with hydrochlorothiazide
Indication :
Hypertension
Group Name :
Keywords :
Brand Names Include :
Cozaar-Comp
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0